glp-1 pharmacology and Anesthesia: Considerations and Cautions for CRNAs GLP-1 receptor agonists and next-generation

The news about how well retatrutide works came this month from Eli Lilly, the drugs manufacturer

Knowing whether your plan requires a diagnosis of type 2 diabetes versus a diagnosis of obesity can help you and your doctor choose the right medication to pursue, along with deciding whether you should use GLP-1 and insulin together as part of your treatment plan

2021 Feb 26;13(3):749

That means not limiting GLP-1 coverage to six months or a year, as many insurers do, and providing the same support that made GLP-1s so effective in clinical testing

Some providers extend the time at lower doses if a patient experiences significant GI side effects, and that is perfectly reasonable